Business Segment Information (Tables)

9 Months Ended

Jul. 31, 2024

Segment Reporting [Abstract]

Schedule of segment information

Segment information:

Periods Ended July 31,	Three Months				Nine Months
(In millions)	2024		2023		2024		2023
CooperVision net sales by category:
Toric and multifocal	$	326.4	$	296.5	$	934.0	$	838.5
Sphere, other	349.2		333.7		999.0		962.3
Total CooperVision net sales	$	675.6	$	630.2	$	1,933.0	$	1,800.8
CooperSurgical net sales by category:
Office and surgical	$	197.9	$	178.4	$	571.9	$	506.6
Fertility	129.3		121.6		372.1		358.7
Total CooperSurgical net sales	327.2		300.0		944.0		865.3
Total net sales	$	1,002.8	$	930.2	$	2,877.0	$	2,666.1
Operating income (loss):
CooperVision	$	172.7	$	151.7	$	487.7	$	449.7
CooperSurgical	41.3		18.8		86.9		0.3
Corporate	(21.5)		(18.9)		(67.3)		(52.6)
Total operating income	192.5		151.6		507.3		397.4
Interest expense	28.5		26.8		87.3		79.0
Other expense, net	0.3		6.0		6.3		11.9
Income before income taxes	$	163.7	$	118.8	$	413.7	$	306.5

Schedule of identifiable assets by segment

(In millions)	July 31, 2024		October 31, 2023
Total identifiable assets:
CooperVision	$	7,172.0	$	7,044.0
CooperSurgical	4,716.8		4,351.8
Corporate	219.2		263.1
Total	$	12,108.0	$	11,658.9

Schedule of net sales to unaffiliated customers by country of domicile

Geographic information:

Periods Ended July 31,	Three Months				Nine Months
(In millions)	2024		2023		2024		2023
Net sales to unaffiliated customers by country of domicile:
United States	$	511.2	$	462.5	$	1,460.6	$	1,340.4
Europe	297.0		279.7		850.3		777.4
Rest of world	194.6		188.0		566.1		548.3
Total	$	1,002.8	$	930.2	$	2,877.0	$	2,666.1

Schedule of net property, plant and equipment by country of domicile

(In millions)	July 31, 2024		October 31, 2023
Net property, plant and equipment by country of domicile:
United States	$	1,094.1	$	1,027.6
Europe	377.9		325.9
Rest of world	275.6		279.1
Total	$	1,747.6	$	1,632.6